Assessment of Alpha-adrenergic Receptor Subtypes in Isolated Rat Aortic Segments
Overview
Authors
Affiliations
The postsynaptic alpha-adrenoceptors in the isolated rat aorta have been characterized according to the sensitivity of the tissue to selective alpha 1- and alpha 2-adrenoceptor agonists and antagonists. The potency (-log EC50) order of the non-selective alpha-agonist norepinephrine and relatively selective agonists was as follows: norepinephrine (alpha 1 = alpha 2; 7.30); clonidine (alpha 2 greater than alpha 1; 7.01); phenylephrine (alpha 1 greater than alpha 2; 6.99), SK & F 89748--A (alpha 1 greater than alpha 2; 6.65); BHT-920 (alpha 2 much greater than alpha 1; 5.56) and M-7 (alpha 2 greater than alpha 1; 4.66). The isolated rat aorta was 12-200-fold more sensitive to the alpha 1-adrenoceptor agonists phenylephrine and SK & F 89748-A, than to the alpha 2-agonists, BHT-920 and M-7. Prazosin is 245-1259-fold more potent than rauwolscine as an antagonist of contractions induced by various alpha 1- and alpha 2-agonists in the rat aorta. These data indicate that constriction of the smooth muscle of the rat aorta to alpha-adrenergic agonists is mediated through alpha 1- but not alpha 2-adrenoceptors.
Holwerda S, Luehrs R, DuBose L, Collins M, Wooldridge N, Stroud A Hypertension. 2019; 73(5):1025-1035.
PMID: 30905199 PMC: 6937199. DOI: 10.1161/HYPERTENSIONAHA.118.12462.
The effect of chlorpyrifos on isolated thoracic aorta in rats.
Yildirim E, Baydan E, Kanbur M, Kul O, Cinar M, Ekici H Biomed Res Int. 2013; 2013:376051.
PMID: 23878805 PMC: 3708383. DOI: 10.1155/2013/376051.
New insights in the contribution of voltage-gated Na(v) channels to rat aorta contraction.
Fort A, Cordaillat M, Thollon C, Salazar G, Mechaly I, Villeneuve N PLoS One. 2009; 4(10):e7360.
PMID: 19809503 PMC: 2752992. DOI: 10.1371/journal.pone.0007360.
Crassous P, Flavahan S, Flavahan N Br J Pharmacol. 2009; 158(5):1344-55.
PMID: 19785657 PMC: 2782344. DOI: 10.1111/j.1476-5381.2009.00403.x.
Raasch W, Schafer U, Qadri F, Dominiak P Br J Pharmacol. 2002; 135(3):663-72.
PMID: 11834614 PMC: 1573177. DOI: 10.1038/sj.bjp.0704513.